Fuqiang Hu
- Biomaterials top 0.1%
- Molecular Biology top 2%
- Pharmaceutical Science top 0.02%
- Biomedical Engineering top 0.5%
- Food Science top 1%
- Topics
- Nanoparticle-Based Drug Delivery (82 papers)RNA Interference and Gene Delivery (53 papers)Nanoplatforms for cancer theranostics (50 papers)
- Partner nations
- ChinaCzechiaUnited States
In The Last Decade
Fuqiang Hu
199 papers receiving 9.1k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Biomaterials 3.8k
- Molecular Biology 3.6k
- Pharmaceutical Science 3.1k
- Biomedical Engineering 2.5k
- Food Science 845
Countries citing papers authored by Fuqiang Hu
This map shows the geographic impact of Fuqiang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuqiang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuqiang Hu more than expected).
Fields of papers citing papers by Fuqiang Hu
This network shows the impact of papers produced by Fuqiang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuqiang Hu. The network helps show where Fuqiang Hu may publish in the future.
Co-authorship network of co-authors of Fuqiang Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Fuqiang Hu. A scholar is included among the top collaborators of Fuqiang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuqiang Hu. Fuqiang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 10 | |
| 4 | 7 | |
| 5 | 1 | |
| 6 | 21 | |
| 7 | 13 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 28 | |
| 11 | 10 | |
| 12 | 7 | |
| 13 | 60 | |
| 14 | 22 | |
| 15 | 32 | |
| 16 | 12 | |
| 17 | 19 | |
| 18 | 30 | |
| 19 | 51 | |
| 20 | Knockdown of the inflammatory factor pentraxin-3 suppresses growth and invasion of lung adenocarcinoma through the AKT and NF-kappa B pathways. | 16 |
About Fuqiang Hu
Fuqiang Hu is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology, having authored 203 papers that have together received 9.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (82 papers), RNA Interference and Gene Delivery (53 papers) and Nanoplatforms for cancer theranostics (50 papers). The work is most often cited by research in Pharmaceutical Science (3.1k citations), Biomaterials (3.8k citations) and Molecular Medicine (435 citations). Fuqiang Hu has collaborated with scholars based in China, Czechia and United States. Frequent co-authors include Hong Yuan, Yongzhong Du, Jian You, Su Zeng, Hong Yuan, Wei Wu, Tingting Meng, Yi Lü, Yi-Qing Ye and Saiping Jiang. Their work appears in journals such as Advanced Materials, Angewandte Chemie International Edition and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.